Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine (Q40779855)

23 September 2017

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine (English)

1 reference

pneumococcal conjugate vaccine

23 September 2017

0 references

1 reference

2

Ruth Lynfield

1 reference

23 September 2017

3

William Schaffner

1 reference

23 September 2017

17

Lindsay Kim

1 reference

23 September 2017

8

Shelley M Zansky

1 reference

23 September 2017

12

Monica M Farley

1 reference

23 September 2017

11

Lee H Harrison

1 reference

23 September 2017

6

Susan Petit

1 reference

23 September 2017

4

Arthur Reingold

1 reference

23 September 2017

16

Tracy Pondo

1 reference

23 September 2017

10

Joan Baumbach

1 reference

23 September 2017

13

Bernard Beall

1 reference

23 September 2017

14

Lesley McGee

1 reference

23 September 2017

7

Corinne Holtzman

1 reference

23 September 2017

15

Ryan Gierke

1 reference

23 September 2017

Sara Tomczyk

1

1 reference

23 September 2017

Lisa Miller

series ordinal

5

1 reference

23 September 2017

Ann Thomas

series ordinal

9

1 reference

23 September 2017

language of work or name

English

0 references

publication date

7 February 2016

1 reference

Clinical Infectious Diseases

23 September 2017

1 reference

23 September 2017

62

1 reference

23 September 2017

9

1 reference

23 September 2017

1119-1125

1 reference

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

23 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

The burden of community-acquired pneumonia in seniors: results of a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Healthcare utilization and cost of pneumococcal disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Differential effects of pneumococcal vaccines against serotypes 6A and 6C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Shifting genetic structure of invasive serotype 19A pneumococci in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

The perpetual challenge of antimicrobial resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

Increase in pneumococcus macrolide resistance, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW067

21 January 2018

Identifiers

DOI

10.1093/CID/CIW067

1 reference

23 September 2017

1 reference